• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Europe Medical Cannabis Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The Europe medical cannabis market is currently witnessing moderate growth. Medical cannabis, or medical marijuana, refers to the plant-derived psychotropic drugs used for the treatment of various medical ailments. It is usually sourced from cannabis indica, sativa and hybrid cannabis plants and the active ingredients include tetrahydrocannabinol (THC) and cannabidiol (CBD). Medical cannabis products are manufactured in the form of oils, capsules and other edible products. They are used for treating chronic pain, anxiety, anorexia, muscle spasms and nausea. Apart from this, they are also effective in modulating the immune system, promoting neuroplasticity and improving vascular and digestive functioning.

The increasing prevalence of chronic medical ailments, such as cancer, arthritis, Alzheimer’s and migraine, is one of the key factors creating a positive outlook for the market. Furthermore, the widespread adoption of medical cannabis for pain management is providing a thrust to the market growth. It is usually inhaled, smoked, orally administered or topically applied to numb the pain receptors and provide instant relief to the patients. Additionally, the legalization of medical cannabis in Europe has enhanced the accessibility of the products through healthcare centers and authorized dispensaries, thereby contributing to the market growth. Other factors, including, extensive research and development (R&D) activities for optimizing the use of cannabinoids, along with improvements in the healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the market to witness moderate growth during 2021-2026.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe medical cannabis market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, species, derivative, application, end use and route of administration.

Breakup by Species:

  • Indica
  • Sativa
  • Hybrid
     

Breakup by Derivative:

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others
     

Breakup by Application:

  • Cancer
  • Arthritis
  • Migraine
  • Epilepsy
  • Others
     

Breakup by End Use:

  • Pharmaceutical Industry
  • Research and Development Centres
  • Others
     

Breakup by Route of Administration:

  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others
     

Breakup by Country:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the Europe medical cannabis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Europe medical cannabis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the species?
  • What is the breakup of the market based on the derivative?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the Europe medical cannabis market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Europe Medical Cannabis Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Species
    6.1    Indica
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Sativa
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Hybrid
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Derivative
    7.1    Cannabidiol (CBD)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Tetrahydrocannabinol (THC)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Cancer
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Arthritis
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Migraine
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Epilepsy
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by End Use
    9.1    Pharmaceutical Industry
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Research and Development Centres
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Route of Administration
    10.1    Oral Solutions and Capsules
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Smoking
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Vaporizers
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Topicals
        10.4.1 Market Trends
        10.4.2 Market Forecast
    10.5    Others
        10.5.1 Market Trends
        10.5.2 Market Forecast
11    Market Breakup by Country
    11.1    Germany
        11.1.1 Market Trends
        11.1.2 Market Breakup by Species
        11.1.3 Market Breakup by Derivative 
        11.1.4 Market Breakup by Application
        11.1.5 Market Breakup by End Use
        11.1.6 Market Breakup by Route of Administration
        11.1.7 Market Forecast
    11.2    France
        11.2.1 Market Trends
        11.2.2 Market Breakup by Species
        11.2.3 Market Breakup by Derivative 
        11.2.4 Market Breakup by Application
        11.2.5 Market Breakup by End Use
        11.2.6 Market Breakup by Route of Administration
        11.2.7 Market Forecast
    11.3    United Kingdom
        11.3.1 Market Trends
        11.3.2 Market Breakup by Species
        11.3.3 Market Breakup by Derivative 
        11.3.4 Market Breakup by Application
        11.3.5 Market Breakup by End Use
        11.3.6 Market Breakup by Route of Administration
        11.3.7 Market Forecast
    11.4    Italy
        11.4.1 Market Trends
        11.4.2 Market Breakup by Species
        11.4.3 Market Breakup by Derivative 
        11.4.4 Market Breakup by Application
        11.4.5 Market Breakup by End Use
        11.4.6 Market Breakup by Route of Administration
        11.4.7 Market Forecast
    11.5    Spain
        11.5.1 Market Trends
        11.5.2 Market Breakup by Species
        11.5.3 Market Breakup by Derivative 
        11.5.4 Market Breakup by Application
        11.5.5 Market Breakup by End Use
        11.5.6 Market Breakup by Route of Administration
        11.5.7 Market Forecast
    11.6    Others
        11.6.1 Market Trends
        11.6.2 Market Breakup by Species
        11.6.3 Market Breakup by Derivative 
        11.6.4 Market Breakup by Application
        11.6.5 Market Breakup by End Use
        11.6.6 Market Breakup by Route of Administration
        11.6.7 Market Forecast
12    SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15    Policy and Regulatory Landscape
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players

List of Figures

Figure 1: Europe: Medical Cannabis Market: Major Drivers and Challenges
Figure 2: Europe: Medical Cannabis Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 5: Europe: Medical Cannabis Market: Breakup by Derivative (in %), 2020
Figure 6: Europe: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 7: Europe: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 8: Europe: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 9: Europe: Medical Cannabis Market: Breakup by Country (in %), 2020
Figure 10: Europe: Medical Cannabis (Indica) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Europe: Medical Cannabis (Indica) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Europe: Medical Cannabis (Sativa) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Europe: Medical Cannabis (Sativa) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Europe: Medical Cannabis (Hybrid) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Europe: Medical Cannabis (Hybrid) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Europe: Medical Cannabis (Cannabidiol-CBD) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Europe: Medical Cannabis (Cannabidiol-CBD) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Europe: Medical Cannabis (Tetrahydrocannabinol-THC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Europe: Medical Cannabis (Tetrahydrocannabinol-THC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Europe: Medical Cannabis (Other Derivatives) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Europe: Medical Cannabis (Other Derivatives) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Europe: Medical Cannabis (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Europe: Medical Cannabis (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Europe: Medical Cannabis (Arthritis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Europe: Medical Cannabis (Arthritis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Europe: Medical Cannabis (Migraine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Europe: Medical Cannabis (Migraine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Europe: Medical Cannabis (Epilepsy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Europe: Medical Cannabis (Epilepsy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Europe: Medical Cannabis (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Europe: Medical Cannabis (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Europe: Medical Cannabis (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Europe: Medical Cannabis (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Europe: Medical Cannabis (Research and Development Centres) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Europe: Medical Cannabis (Research and Development Centres) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Europe: Medical Cannabis (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Europe: Medical Cannabis (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Europe: Medical Cannabis (Oral Solutions and Capsules) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Europe: Medical Cannabis (Oral Solutions and Capsules) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Europe: Medical Cannabis (Smoking) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Europe: Medical Cannabis (Smoking) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Europe: Medical Cannabis (Vaporizers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Europe: Medical Cannabis (Vaporizers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Europe: Medical Cannabis (Topicals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Europe: Medical Cannabis (Topicals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Europe: Medical Cannabis (Other Route of Administrations) Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Europe: Medical Cannabis (Other Route of Administrations) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Germany: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Germany: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 50: Germany: Medical Cannabis Market: Breakup by Derivative (in %), 2020 
Figure 51: Germany: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 52: Germany: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 53: Germany: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 54: Germany: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: France: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: France: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 57: France: Medical Cannabis Market: Breakup by Derivative (in %), 2020 
Figure 58: France: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 59: France: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 60: France: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 61: France: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: United Kingdom: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: United Kingdom: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 64: United Kingdom: Medical Cannabis Market: Breakup by Derivative (in %), 2020 
Figure 65: United Kingdom: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 66: United Kingdom: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 67: United Kingdom: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 68: United Kingdom: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Italy: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Italy: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 71: Italy: Medical Cannabis Market: Breakup by Derivative (in %), 2020 
Figure 72: Italy: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 73: Italy: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 74: Italy: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 75: Italy: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Spain: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Spain: Medical Cannabis Market: Breakup by Species (in %), 2020
Figure 78: Spain: Medical Cannabis Market: Breakup by Derivative (in %), 2020 
Figure 79: Spain: Medical Cannabis Market: Breakup by Application (in %), 2020
Figure 80: Spain: Medical Cannabis Market: Breakup by End Use (in %), 2020
Figure 81: Spain: Medical Cannabis Market: Breakup by Route of Administration (in %), 2020
Figure 82: Spain: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026 
Figure 83: Others: Medical Cannabis Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Medical Cannabis Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Europe: Medical Cannabis Industry: SWOT Analysis
Figure 86: Europe: Medical Cannabis Industry: Value Chain Analysis
Figure 87: Europe: Medical Cannabis Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Europe: Medical Cannabis Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Medical Cannabis Market Forecast: Breakup by Species (in Million US$), 2021-2026
Table 3: Europe: Medical Cannabis Market Forecast: Breakup by Derivative (in Million US$), 2021-2026
Table 4: Europe: Medical Cannabis Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Europe: Medical Cannabis Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 6: Europe: Medical Cannabis Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 7: Europe: Medical Cannabis Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 8: Europe: Medical Cannabis Market: Competitive Structure
Table 9: Europe: Medical Cannabis Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links